Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start ...

NIVACOR: Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab in first-line chemotherapy for advanced colorectal cancer RASm/BRAFm patients. TRACC: Tracking mutations in cell-free DNA ...

In cancer treatment, surgery remains the best option for removing tumors from affected patients. Successful resection is achieved by the complete removal of tumor cells so as not to cause a resurgence ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National ...

Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...

Fluorescence has been used in many different scientific fields including life sciences research and medical applications. The use of fluorescence in surgeries, including those that treat glioblastomas ...

Tokyo / Hamburg, Jan 28, 2021 - (ACN Newswire) - - Olympus Corporation (Olympus - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced that it has entered ...